Acquired Cystic Kidney Disease

How to Cite This Chapter: Lanktree MB, Nowicki M, Drabczyk R. Acquired Cystic Kidney Disease. McMaster Textbook of Internal Medicine. Kraków: Medycyna Praktyczna. https://empendium.com/mcmtextbook/chapter/B31.II.14.9.3. Accessed April 24, 2024.
Last Updated: February 10, 2022
Last Reviewed: February 10, 2022
Chapter Information

Definition, Etiology, PathogenesisTop

Acquired cystic kidney disease refers to the presence of ≥4 cysts involving both kidneys with atrophy and a reduction of overall kidney size after development of advanced chronic kidney disease (CKD). Acquired cystic kidney disease may develop regardless of CKD etiology and should not be confused with polycystic kidney disease. Acquired cystic kidney disease is common in patients undergoing renal replacement therapy (5%-20%), with incidence rising with dialysis vintage (length of time on dialysis). While etiology is unknown, proximal tubular cell proliferation is thought to be important. In the majority of cases cysts remain asymptomatic, but they may cause episodes of hematuria, chronic flank pain, or renal colic. Acquired cystic kidney disease is associated with risk of renal cell carcinoma, which may occur in up to 7% of patients. In 25% to 50% of renal cell carcinoma cases the tumor is multifocal and/or bilateral.

Diagnosis Top

Diagnosis is based on ultrasonography followed by computed tomography (CT) or magnetic resonance imaging (MRI) for questionable lesions. Screening would occur during evaluation for transplant. Screening is not recommended in patients with limited life expectancy but can be considered in patients who have long life expectancies 3 to 5 years following the initiation of kidney replacement therapy or after renal transplant.

Treatment Top

No specific treatment is required. Episodes of hematuria are treated symptomatically. Interventional radiologic or surgical treatment may be necessary in case of retroperitoneal bleeding from a cyst, persistent or severe hematuria, cyst infection not responding to medical treatment, and suspected or confirmed renal cell carcinoma.

We would love to hear from you

Comments, mistakes, suggestions?

We use cookies to ensure you get the best browsing experience on our website. Refer to our Cookies Information and Privacy Policy for more details.